Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds
Zixiang Li1, Wen Si2, Wenke Jin1
1Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.
Abstract:
Autophagy, an evolutionarily highly conserved cellular degradation process, plays the Janus role (either cytoprotective or death-promoting) in colorectal cancer, so the targeting of several key autophagic pathways with small-molecule compounds may be a new therapeutic strategy. In this review, we discuss autophagy-associated cell death pathways and key cytoprotective autophagy pathways in colorectal cancer. Moreover, we summarize a series of small-molecule compounds that have the potential to modulate autophagy-associated cell death or cytoprotective autophagy for therapeutic purposes. Taken together, these findings demonstrate the Janus role of autophagy in colorectal cancer, and shed new light on the exploitation of a growing number of small-molecule compounds to target autophagy in future cancer drug discovery.
Insights
Autophagy plays a dual role in colorectal cancer, acting as both a protector and promoter of cancer cell death. Targeting autophagy pathways with small molecules offers a promising therapeutic strategy for colorectal cancer drug discovery.
Area of Science:
- Cellular Biology
- Oncology
- Molecular Medicine
Background:
- Autophagy is a fundamental cellular process involved in degradation and recycling.
- Its role in colorectal cancer is complex, exhibiting both tumor-suppressive and tumor-promoting functions.
- Understanding this dual role is crucial for developing effective cancer therapies.
Purpose of the Study:
- To review the dual role of autophagy in colorectal cancer.
- To discuss autophagy-associated cell death and cytoprotective pathways.
- To summarize small-molecule compounds targeting autophagy for therapeutic potential.
Main Methods:
- Literature review of autophagy pathways in colorectal cancer.
- Analysis of small-molecule compounds modulating autophagy.
- Synthesis of current understanding on autophagy's role in colorectal cancer.
Main Results:
- Autophagy can promote colorectal cancer cell survival or induce cell death.
- Specific autophagy pathways are critical in colorectal cancer progression.
- Numerous small-molecule compounds show potential to modulate these pathways.
Conclusions:
- Autophagy's Janus role in colorectal cancer necessitates context-specific therapeutic targeting.
- Small-molecule modulators of autophagy represent a promising avenue for colorectal cancer drug discovery.
- Targeting autophagy offers a novel strategy for future cancer therapeutics.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

